Load for improving curative effect of flavonoid compound, preparation method and application

The preparation of sporonin-loaded flavonoids by treating pine pollen has solved the problem of low bioavailability of flavonoids, significantly improved their anti-osteoporosis efficacy, and provided a green and environmentally friendly nanomaterial suitable for traditional Chinese medicine and health foods.

CN118948794APending Publication Date: 2024-11-15佟昕桐
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411146074.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The low oral bioavailability of flavonoids leads to limited efficacy in drug preparations and health foods, making it difficult to effectively prevent and treat osteoporosis.

Method used

Pine pollen is used as the microcapsule carrier, and the flavonoids are prepared by washing, degreasing, acidolysis and alkaline lysis to improve their bioavailability.

Benefits of technology

It significantly improves the bioavailability and anti-osteoporosis efficacy of flavonoids, and provides a green, environmentally friendly and low-cost nanomaterial suitable for traditional Chinese medicine and health food fields.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948794A_ABST
    Figure CN118948794A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of traditional Chinese medicine and health food, and particularly relates to a load for improving the curative effect of a flavonoid compound, a preparation method and application. The load for improving the curative effect of the flavonoid compound is composed of sporopollen loaded flavonoid compounds. Washing, degreasing, deproteinizing, adjusting wettability, centrifuging, drying and the like to obtain sporopollen; the preparation method comprises the following steps: dispersing sporopollen in a flavonoid compound soluble ethanol solution, stirring, soaking, filtering, drying and the like to obtain the sporopollen load. The nano material of the flavonoid compound prepared by taking the pine pollen as the micro-capsule carrier has high bioavailability so as to improve the anti-osteoporosis curative effect, and the method is simple, convenient to operate, good in reproducibility, green and environment-friendly, and has wide prospects in the fields of traditional Chinese medicines and health-care foods.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicine and health food, and particularly relates to a loading material for improving the therapeutic effect of flavonoid compounds, a preparation method and application thereof. Background Art

[0002] As we all know, pollen is both medicine and food, green and environmentally friendly. Sporopollenin has a microcapsule structure and is an ideal substitute for artificial materials. Since the microcapsule structure is easy to absorb, it can be used as a carrier for oral drugs with low bioavailability to improve their bioavailability and ensure therapeutic efficacy.

[0003] Natural pollen can be chemically treated to obtain hollow microcapsule carriers with micro-nano structures. These carriers retain the inherent three-dimensional nanostructure and have extremely strong physical and chemical stability and heat resistance. After drug loading, they can ensure the efficacy of drugs by improving the bioavailability of drugs, and have application potential in the biomedicine field. Different pollen processing methods result in different three-dimensional nanostructures, resulting in different drug preferences and drug loading capacities. How to improve the drug loading capacity is a major challenge that hinders the practical application of most pollens as nanomaterials.

[0004] Chinese patent CN111067944A discloses a pollen nanoporous microsphere and its preparation method and application. The patent pre-treats the peony pollen to initially inhibit pollen germination, then sieves it; soaks the sieved pollen in an ethanol solution with a volume fraction of 75-100% for 5-15 minutes; centrifuges and discards the supernatant; then treats it with a slightly alkaline solution for 8-15 minutes; centrifuges and discards the supernatant; finally rinses and dries it to obtain hollow natural degradable nanoporous microspheres (sporopollenin).

[0005] Chinese patent CN1116172967 A discloses the use of sporopollenin as a pharmaceutical excipient in pharmaceutical preparations. The patent elaborates on the use of sporopollenin as a pharmaceutical excipient in pharmaceutical preparations: including sporopollenin as a microcapsule carrier, curing agent, filler, and sustained-release skeleton material; pharmaceutical preparations include tablets, pills, suspensions, capsules, gastric floating preparations, sustained-release tablets, enteric-coated tablets, and granules; it also specifically mentions sporopollenin as a curing agent for oil-based drugs, a filler for traditional Chinese medicine, chemical drugs, or biological drugs; loading unstable drugs into the microcapsule structure of sporopollenin to achieve a stabilizing effect; and as a carrier for controlled-release, sustained-release, and gastric drifting preparations. The pollens involved include sporopollenin from sunflower, rapeseed, Codonopsis pilosula, Elaeagnus angustifolia, Leonurus japonicus pine pollen, and wild chrysanthemum.

[0006] Chinese patent CN109549969 A discloses a flavonoid health product for preventing and treating osteoporosis and its preparation method. The flavonoid health product for preventing and treating osteoporosis in the patent includes: epimedium extract (total flavonoid content: 5-10%), soybean extract (5-10%), hops extract (5-10%), eucommia extract (2-5%), kudzu root extract (2-5%), drynaria extract (2-5%), and the mass ratio of the extracts is 3:2:2:1:1:1.

[0007] Osteoporosis is a common disease among the middle-aged and elderly. It is a metabolic bone disease and a degenerative disease, resulting in decreased bone density. After searching the literature on Chinese medicine for anti-osteoporosis, the results showed that most of the drugs were composed of soybeans, epimedium, and psoralea corylifolia. Modern pharmacological studies have shown that flavonoids are the main components of this type of drug, but the oral bioavailability of this type of compound is low, in most cases in the range of 2-20%, and a large number of animal experimental results show that the oral bioavailability of this type of compound is often less than 10%. The low oral bioavailability makes it very difficult to develop flavonoids into pharmaceutical preparations and health foods with practical application value. Summary of the invention

[0008] The purpose of the present invention is to provide a loading material, a preparation method and an application for improving the therapeutic effect of flavonoid compounds, and to provide a microcapsule carrier using pine pollen (derived from Pinus massoniana Lamb, a plant of the Pinaceae family) to increase the drug loading capacity by modifying the pollen, thereby solving the problem of low oral bioavailability of flavonoid compounds.

[0009] To achieve the above objectives, this application is implemented through the following technical solutions:

[0010] A loading substance for improving the therapeutic effect of flavonoid compounds consists of sporopollenin loaded with flavonoid compounds.

[0011] Furthermore, the weight ratio of the sporopollenin to the flavonoids is 1:1-100.

[0012] The method for preparing any of the above-mentioned loading materials for improving the therapeutic effect of flavonoid compounds comprises the following steps:

[0013] S1, washing and sieving the pollen to remove hydrophilic substances and impurities in the pollen to obtain pure pollen;

[0014] S2, removing lipids from the purified pollen by reflux of ethanol to obtain defatted pollen;

[0015] S3, removing protein from the defatted pollen by acidification to obtain acid-defatted pollen;

[0016] S4, modifying the acid-defatted pollen by alkaline hydrolysis to obtain sporopollenin;

[0017] S5, loading the sporopollenin with flavonoid compounds to obtain a sporopollenin loaded material.

[0018] Furthermore, in step S1, the pollen is selected from one or more of pine pollen, rapeseed pollen, lotus or camellia pollen.

[0019] Furthermore, in step S1, the preparation steps of pure pollen are:

[0020] S11, dispersing the pollen in deionized water to disperse the pollinia into powder;

[0021] S12, passing the filtrate through a sieve with a set mesh size to remove impurities in the pollen;

[0022] S13. After filtering, the filter cake is dispersed again in deionized water, and washed repeatedly until the filtrate is colorless, and the pollen is collected and dried to obtain pure pollen.

[0023] Furthermore, in step S2, the preparation steps of defatted pollen are:

[0024] S21, adding the pure pollen to ethanol with a volume percentage concentration of 10-100%, and reflux at 50-100° C. for 1-25 hours;

[0025] S22, filter and wash thoroughly with 80-100°C hot water until the filtrate is colorless, collect the solid and dry it to obtain defatted pollen.

[0026] Furthermore, in step S3, the preparation steps of the acid-defatted pollen are:

[0027] S31, adding the defatted pollen to phosphoric acid having a volume percentage concentration of 10-85%, and stirring at 25-80° C. for 1-25 hours;

[0028] S32, filter and wash thoroughly with hot water until the filtrate is colorless, collect the solid and dry it to obtain acid-defatted pollen.

[0029] Further, in step S4, the preparation steps of sporopollenin are:

[0030] S41, adding the acid-defatted pollen to 0.1-10 mol / L sodium hydroxide, and stirring at 25-80° C. for 1-25 hours;

[0031] S42, centrifugation, washing and drying to obtain sporopollenin.

[0032] Furthermore, in step S5, the weight ratio of sporopollenin to flavonoids is 1:1-100, and the specific steps are: dissolving the flavonoids in 10-100% by volume ethanol, adding sporopollenin, vortexing for 5-30 minutes, stirring the mixture for 2-6 hours, filtering, and drying the solid at 25°C for 24-48 hours to obtain a sporopollenin load.

[0033] An application, use of any of the above-mentioned sporopollenin loading materials in medicines or health foods.

[0034] Compared with the prior art, the present invention has the following beneficial effects:

[0035] (1) After adopting the technical solution of the present invention, natural pollen is used as a biological carrier, which is cheap, easy to obtain, green and environmentally friendly, and overcomes the problems of high cost and environmental pollution of previous nanomaterials.

[0036] (2) In the technical solution of the present invention, the nanomaterials loaded with flavonoid compounds can improve the anti-osteoporosis efficacy compared with common excipients.

[0037] 3) The nanomaterial of flavonoid compounds prepared by using pine pollen as microcapsule carrier has high bioavailability, simple method, convenient operation, good reproducibility, and is green and environmentally friendly, and has broad prospects in the fields of traditional Chinese medicine and health food. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 This is a microscope image of untreated pine pollen.

[0039] Figure 2 This is a microscope picture of defatted pine pollen.

[0040] Figure 3 This is a microscopic image of pine pollen (sporopollenin) after acid treatment.

[0041] Figure 4 This is a microscope image of pine pollen (sporopollenin) after acid treatment and then alkali treatment.

[0042] Figure 5 This is a microscopic picture of pine pollen sporopollenin loaded with flavonoid compounds. DETAILED DESCRIPTION

[0043] The technical solution of the present invention is described in detail below through examples. The following examples are merely exemplary and can only be used to explain and illustrate the technical solution of the present invention, but cannot be construed as limiting the technical solution of the present invention.

[0044] Example 1

[0045] like Figures 1 to 5As shown, the present application provides a preparation method for improving the efficacy of flavonoid compounds in anti-osteoporosis drugs, which comprises the following steps:

[0046] S1. Preparation of sporopollenin:

[0047] Disperse 30g of pine pollen in 10 times the volume of deionized water and pass through an 80-mesh sieve to disperse the pollen blocks into powder and remove the hydrophilic compounds in the pollen. Filter with a vacuum filtration device and disperse the filter cake again in deionized water. Wash repeatedly 3-5 times until the filtrate is basically colorless. Dry the recovered pine pollen in an oven at 60°C.

[0048] The dried pine pollen was added to anhydrous ethanol and refluxed at 80°C for 1 h. The suspension was filtered with a vacuum filtration device and washed thoroughly with hot water until the filtrate was basically colorless. The defatted pollen was recovered and then placed in a drying oven and dried at 60°C for 24 h to obtain dry defatted pollen.

[0049] Acid hydrolysis to remove protein: Add the dried defatted pollen to 85% by volume phosphoric acid, stir for 16 h at 70 °C using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60 °C for 24 h to obtain acid-hydrolyzed sporopollenin.

[0050] Alkaline hydrolysis to adjust wettability: add acid-hydrolyzed sporopollenin to 2 mol / L sodium hydroxide, stir at a certain temperature for 18 h using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60°C for 24 h to obtain alkali-modified pine pollen sporopollenin.

[0051] Determination of protein content by biuret reagent method: accurately measure 2.0 mL of the filtrate obtained in the alkaline hydrolysis step, add biuret reagent A solution to adjust the filtrate to neutrality, then add 1.0 mL of A solution and 2-3 drops of B solution, and react fully in an ice bath. Use 3.0 mL of deionized water, 3.0 mL of biuret reagent A solution and 2-3 drops of B solution as a blank reagent. After the reaction is complete, use an ultraviolet spectrophotometer to measure the absorbance of each filtrate at λ=540 nm.

[0052] S2. Preparation of flavonoid compound sporopollenin: Passive loading technology is used, and the steps are as follows: 0.5g of total flavonoid powder (consisting of 1546 parts of total flavonoids from soybean, 635 parts of total flavonoids from epimedium, and 476 parts of total flavonoids from psoralea corylifolia) is dissolved in 20mL of 60% ethanol, and 1.0g of alkali-modified pine pollen sporopollenin is added. After vortexing for 10 minutes, the mixture is continuously stirred (4°C, 350rpm) and incubated for 4h, and the sporopollenin loaded with total flavonoids is filtered. The pine pollen sporopollenin loaded with total flavonoids is dried at 25°C for 24h, stored, and used for standby.

[0053] Example 2

[0054] A preparation method for improving the efficacy of flavonoid anti-osteoporosis drugs, comprising the following steps:

[0055] S1. Preparation of sporopollenin:

[0056] Disperse 30g of pine pollen in 10 times the volume of deionized water and pass through an 80-mesh sieve to disperse the pollen blocks into powder and remove the hydrophilic compounds in the pollen. Filter with a vacuum filtration device and disperse the filter cake again in deionized water. Wash repeatedly 3-5 times until the filtrate is basically colorless. Dry the recovered pine pollen in an oven at 60°C.

[0057] The dried pine pollen was added to anhydrous ethanol and refluxed at 80°C for 1 h. The suspension was filtered with a vacuum filtration device and washed thoroughly with hot water until the filtrate was basically colorless. The defatted pollen was recovered and then placed in a drying oven and dried at 60°C for 24 h to obtain dry defatted pollen.

[0058] Acid hydrolysis to remove protein: Add the dried defatted pollen to 85% by volume phosphoric acid, stir for 16 h at 70 °C using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60 °C for 24 h to obtain acid-hydrolyzed sporopollenin.

[0059] Alkaline hydrolysis to adjust wettability: add acid-hydrolyzed sporopollenin to 2 mol / L sodium hydroxide, stir at a certain temperature for 18 h using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60°C for 24 h to obtain alkali-modified pine pollen sporopollenin.

[0060] Determination of protein content by biuret reagent method: accurately measure 2.0 mL of the filtrate obtained in the alkaline hydrolysis step, add biuret reagent A solution to adjust the filtrate to neutrality, then add 1.0 mL of A solution and 2-3 drops of B solution, and react fully in an ice bath. Use 3.0 mL of deionized water, 3.0 mL of biuret reagent A solution and 2-3 drops of B solution as a blank reagent. After the reaction is complete, use an ultraviolet spectrophotometer to measure the absorbance of each filtrate at λ=540 nm.

[0061] S2. Preparation of flavonoid compound sporopollenin: Passive loading technology is used, and the steps are as follows: 0.5g of total flavonoid powder (composed of 1500 parts of total flavonoids of soybean, 600 parts of total flavonoids of epimedium, and 400 parts of total flavonoids of psoralea corylifolia) is dissolved in 20mL of 60% ethanol, and 2.0g of alkali-modified pine pollen sporopollenin is added. After vortexing for 10 minutes, the mixture is continuously stirred (4°C, 350rpm) and incubated for 4h, and the sporopollenin loaded with total flavonoids is filtered. The pine pollen sporopollenin loaded with total flavonoids is dried at 25°C for 24h, stored, and used for standby.

[0062] Example 3

[0063] A preparation method for improving the efficacy of flavonoid anti-osteoporosis drugs, comprising the following steps:

[0064] S1. Preparation of sporopollenin:

[0065] Disperse 30g of pine pollen in 10 times the volume of deionized water and pass through an 80-mesh sieve to disperse the pollen blocks into powder and remove the hydrophilic compounds in the pollen. Filter with a vacuum filtration device and disperse the filter cake again in deionized water. Wash repeatedly 3-5 times until the filtrate is basically colorless. Dry the recovered pine pollen in an oven at 60°C.

[0066] The dried pine pollen was added to anhydrous ethanol and refluxed at 80°C for 1 h. The suspension was filtered with a vacuum filtration device and washed thoroughly with hot water until the filtrate was basically colorless. The defatted pollen was recovered and then placed in a drying oven and dried at 60°C for 24 h to obtain dry defatted pollen.

[0067] Acid hydrolysis to remove protein: Add the dried defatted pollen to 85% by volume phosphoric acid, stir for 16 h at 70 °C using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60 °C for 24 h to obtain acid-hydrolyzed sporopollenin.

[0068] Alkaline hydrolysis to adjust wettability: add acid-hydrolyzed sporopollenin to 2 mol / L sodium hydroxide, stir at a certain temperature for 18 h using a heat-collecting constant temperature magnetic stirrer, filter the suspension using a vacuum filtration device, and wash thoroughly with hot water until the filtrate is basically colorless, recover the solid, and then place it in a drying oven at 60°C for 24 h to obtain alkali-modified pine pollen sporopollenin.

[0069] Determination of protein content by biuret reagent method: accurately measure 2.0 mL of the filtrate obtained in the alkaline hydrolysis step, add biuret reagent A solution to adjust the filtrate to neutrality, then add 1.0 mL of A solution and 2-3 drops of B solution, and react fully in an ice bath. Use 3.0 mL of deionized water, 3.0 mL of biuret reagent A solution and 2-3 drops of B solution as a blank reagent. After the reaction is complete, use an ultraviolet spectrophotometer to measure the absorbance of each filtrate at λ=540 nm.

[0070] S2. Preparation of flavonoid compound sporopollenin: Passive loading technology is used, and the steps are as follows: 0.5g of total flavonoid powder (composed of 1600 parts of total flavonoids of soybean, 650 parts of total flavonoids of epimedium, and 500 parts of total flavonoids of psoralea corylifolia) is dissolved in 20mL of 60% ethanol, and 1.5g of alkali-modified pine pollen sporopollenin is added. After vortexing for 10 minutes, the mixture is continuously stirred (4°C, 350rpm) and incubated for 4h, and the sporopollenin loaded with total flavonoids is filtered. The pine pollen sporopollenin loaded with total flavonoids is dried at 25°C for 24h, stored, and used for standby.

[0071] The following animal experiments are used to further illustrate the beneficial effects of the product of the present invention. These experiments are conducted in accordance with the evaluation test method for increasing bone density function in the "Technical Specifications for Inspection and Evaluation of Health Foods" (Ministry of Health, 2003 edition). The product of the present invention is mainly investigated: using pine pollen as a microcapsule carrier to increase the effect of flavonoid compounds on femoral mass, bone mineral content, bone density and bone calcium content in ovariectomized rat models.

[0072] The drug administration group: the ratio of pine pollen sporopollenin to total flavonoids extract was 2:1, and the total flavonoids extract consisted of 1546 parts of soybean total flavonoids, 635 parts of epimedium total flavonoids, and 476 parts of psoralea corylifolia total flavonoids.

[0073] Grouping: The drug group was given 30 times the recommended human dose (1.2g), and starch was used instead of pine pollen microcapsule carrier as the control group, with a dose of 1.2g. At the same time, three control groups were set up: sham operation control group, model control group, and positive control group (1.0mg / Kg body weight of estradiol).

[0074] Methods: Except for the drug-treated group and the control group, rats in all groups underwent ovariectomy and were given the test substance starting from 3 days after surgery. The experimental period was three months.

[0075] Indicators: Femoral dry weight, femoral distal end bone density, femoral midpoint bone density, bone calcium content, as shown in Table 1:

[0076] Table 1 Effects of samples on rat femur weight, bone calcium and bone density

[0077] Note: "*" indicates that the groups in the same column are significantly different from the model control group (P<0.05).

[0078] Conclusion: The bone mineral density and bone calcium content of the drug-treated group were significantly increased compared with those of the model control group (P<0.05), while there were no significant differences in the bone mineral density and bone calcium content of the control group compared with those of the model control group (P>0.05). This proves that using pine pollen as a microencapsulated carrier can improve the efficacy of flavonoid compounds in anti-osteoporosis drugs.

[0079] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A loading substance for improving the therapeutic effect of flavonoid compounds, characterized in that: It is composed of sporopollenin loaded with flavonoids.

2. The loading material for improving the therapeutic effect of flavonoid compounds according to claim 1, characterized in that: The weight ratio of the sporopollenin to the flavonoids is 1:1-100.

3. A method for preparing a loading material for improving the therapeutic effect of flavonoid compounds as claimed in claim 1 or 2, characterized in that: Use the following steps: S1, washing and sieving the pollen to remove hydrophilic substances and impurities in the pollen to obtain pure pollen; S2, removing lipids from the purified pollen by reflux of ethanol to obtain defatted pollen; S3, removing protein from the defatted pollen by acidification to obtain acid-defatted pollen; S4, modifying the acid-defatted pollen by alkaline hydrolysis to obtain sporopollenin; S5, loading the sporopollenin with flavonoid compounds to obtain a sporopollenin loaded material.

4. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S1, the pollen is selected from one or more of pine pollen, rapeseed pollen, lotus pollen or camellia pollen.

5. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S1, the preparation steps of pure pollen are: S11, dispersing the pollen in deionized water to disperse the pollinia into powder; S12, passing the filtrate through a sieve with a set mesh size to remove impurities in the pollen; S13. After filtering, the filter cake is dispersed again in deionized water, and washed repeatedly until the filtrate is colorless, and the pollen is collected and dried to obtain pure pollen.

6. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S2, the preparation steps of defatted pollen are: S21, adding the pure pollen to ethanol with a volume percentage concentration of 10-100%, and reflux at 50-100° C. for 1-25 hours; S22, filter and wash thoroughly with 80-100°C hot water until the filtrate is colorless, collect the solid and dry it to obtain defatted pollen.

7. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S3, the steps of preparing the acid-defatted pollen are: S31, adding the defatted pollen to phosphoric acid having a volume percentage concentration of 10-85%, and stirring at 25-80° C. for 1-25 hours; S32, filter and wash thoroughly with hot water until the filtrate is colorless, collect the solid and dry it to obtain acid-defatted pollen.

8. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S4, the preparation steps of sporopollenin are: S41, adding the acid-defatted pollen to 0.1-10 mol / L sodium hydroxide, and stirring at 25-80° C. for 1-25 hours; S42, centrifugation, washing and drying to obtain sporopollenin.

9. The method for preparing a loading material for improving the therapeutic effect of flavonoid compounds according to claim 3, characterized in that: In step S5, the weight ratio of sporopollenin to flavonoids is 1:1-100, and the specific steps are: dissolving the flavonoids in 10-100% by volume ethanol, adding sporopollenin, vortexing for 5-30 minutes, stirring the mixture for 2-6 hours, filtering, and drying the solid at 25°C for 24-48 hours to obtain a sporopollenin loaded material.

10. An application, characterized in that: Use of the sporopollenin loading material according to any one of claims 1 to 9 in medicines or health foods.

Citation Information

Cited By

  • Volatile oil supported hydrogel composite material as well as preparation method and application thereof

    CN121081530A

  • Astragalus glycoside composite microcapsule, and preparation method and application thereof

    CN122911928A